Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)

BACKGROUND: Most pancreatic cancer patients present with advanced stage at diagnosis with extremely short expected survival and few treatment options. A multimodal palliative approach is necessary for symptom relief and optimisation of health-related quality of life. In a recent open-label trial of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Wode, Kathrin, Hök Nordberg, Johanna, Kienle, Gunver S., Elander, Nils O., Bernhardson, Britt-Marie, Sunde, Berit, Sharp, Lena, Henriksson, Roger, Fransson, Per
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488501/
https://ncbi.nlm.nih.gov/pubmed/32917288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04581-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars